Advertisement
ALC or ENOV or PHG
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. Enovis Corporation (ENOV) vs. Koninklijke Philips N.V. (PHG) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC) leads in market capitalization at approximately $37 billion, reflecting its dominant position in eye care products amid recent vision research collaborations.
- Enovis Corporation (ENOV) offers significant analyst upside potential, with price targets averaging $44.73 from a current level around $23.62, driven by its focus on musculoskeletal solutions.
- Koninklijke Philips N.V. (PHG) provides broad health technology exposure, with recent earnings beats supporting stability near $26 per share.
- ALC shows year-to-date gains around 6.58%, outperforming peers in recent market activity despite sector pressures.
- All three stocks operate in the healthcare sector, with ENOV exhibiting higher volatility (52-week range $21-37.85) compared to ALC's tighter band ($71.55-98.56).
- Recent momentum favors ENOV with a one-month gain of about 3.78%, contrasting ALC's slight decline.
Introduction
This stock comparison evaluates ALC, ENOV, and PHG—all key players in the healthcare and medical devices sector. Investors seeking exposure to specialized medical technologies, such as eye care, orthopedics, and diagnostics, will find value in understanding their relative performance, growth drivers, and market positioning. Amid evolving healthcare demands and recent sector developments, this analysis highlights contrasts in momentum, valuation sensitivity, and strategic catalysts, aiding decisions on portfolio allocation or trading opportunities in a competitive landscape.
ALC Overview and Recent Performance
Alcon Inc. (ALC) is a global leader in eye care, specializing in surgical equipment, vision products, and pharmaceuticals, stemming from its origins as a Novartis spin-off in 2019. Trading around $74 with a $37 billion market cap, its 52-week range spans $71.55 to $98.56. In recent weeks, ALC has experienced modest pressure, with a one-month dip of about 0.72%, though year-to-date returns stand at roughly 6.58%. Sentiment has been bolstered by its annual general meeting outcomes, board changes, and a collaboration with PerZeption Inc. on vision research, signaling innovation momentum despite a recent earnings miss on EPS (earnings per share).
ENOV Overview and Recent Performance
Enovis Corporation (ENOV), formerly Colfax Corporation, develops medical technologies for musculoskeletal procedures, including orthopedics and rehabilitation devices. At approximately $23.62 with a $1.36 billion market cap, its 52-week range is $21.00 to $37.85, indicating higher volatility. Recent market activity shows a one-month rise of around 3.78% but year-to-date declines near 11%, reflecting broader pressures. Analyst optimism persists with strong buy ratings and targets up to $47, ahead of Q1 earnings, as the company advances clinically differentiated solutions amid acquisition integrations.
PHG Overview and Recent Performance
Koninklijke Philips N.V. (PHG) focuses on health technology, including diagnostics, imaging, and patient monitoring systems. Shares hover near $26, within a 52-week range influenced by operational shifts post its electronics rebranding. Recent weeks have seen stable trading with minor pullbacks, supported by a Q4 EPS beat and ongoing recovery from past challenges. Market sentiment reflects resilience in healthcare demand, though broader economic factors temper gains, positioning PHG as a diversified play in the sector.
Trending AI Robots
Tickeron’s Trending AI Robots page curates the top 25 AI trading bots from over 351 available, each leveraging machine learning for real-time signals across thousands of tickers in stocks, ETFs, and crypto. These bots showcase impressive stats: annualized returns from +23.53% to +163.10%, win rates of 51.30% to 88.33%, and profit factors up to 11.70, with average trade durations from 1 day to 49 days. Trading 1 to 18 tickers, they employ diverse strategies like trend following, swing trading, volatility plays, and multi-agent systems tailored to sectors such as semiconductors, industrials, and gold miners—many with risk controls like 3% take-profit/2% stop-loss corridors. This selection highlights bots best suited to current market conditions. Traders can explore these high-performing options for copy trading inspiration.
Head-to-Head Comparison
ALC, ENOV, and PHG share healthcare exposure but diverge in focus: ALC on precision eye care, ENOV on orthopedic growth via M&A (mergers and acquisitions), and PHG on integrated diagnostics. Growth drivers include ALC’s R&D pipeline versus ENOV’s clinical outcomes emphasis. Recent momentum shows ENOV rebounding short-term, while ALC offers stability; risk factors involve regulatory hurdles for all, with ENOV most sensitive to execution post-deals. Valuation-wise, ENOV trades at a discount to targets, contrasting ALC’s premium positioning. Sentiment leans positive for innovation leaders amid sector rotation.
Tickeron AI Verdict
Tickeron’s AI analysis, factoring trend consistency, stability, and catalysts, currently leans toward ALC for its relative market cap strength, research momentum, and year-to-date outperformance, potentially offering lower volatility in healthcare trades. ENOV presents higher reward potential per analysts, while PHG suits diversified exposure—outcomes hinge on broader market dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 0 FA rating(s) are green whileENOV’s FA Score has 0 green FA rating(s), and PHG’s FA Score reflects 1 green FA rating(s).
- ALC’s FA Score: 0 green, 5 red.
- ENOV’s FA Score: 0 green, 5 red.
- PHG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 3 TA indicator(s) are bullish while ENOV’s TA Score has 6 bullish TA indicator(s), and PHG’s TA Score reflects 6 bullish TA indicator(s).
- ALC’s TA Score: 3 bullish, 6 bearish.
- ENOV’s TA Score: 6 bullish, 4 bearish.
- PHG’s TA Score: 6 bullish, 3 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а +1.73% price change this week, while ENOV (@Medical/Nursing Services) price change was -8.41% , and PHG (@Medical/Nursing Services) price fluctuated -3.66% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.52%. For the same industry, the average monthly price growth was -4.78%, and the average quarterly price growth was +19.71%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.53%. For the same industry, the average monthly price growth was -5.85%, and the average quarterly price growth was -5.88%.
Reported Earning Dates
ALC is expected to report earnings on Aug 10, 2026.
ENOV is expected to report earnings on Jul 30, 2026.
PHG is expected to report earnings on Jul 28, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-4.52% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.53% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ALC | ENOV | PHG | |
| Capitalization | 31.5B | 1.4B | 24.6B |
| EBITDA | 2.54B | -770.33M | 2.68B |
| Gain YTD | -19.249 | -8.821 | -3.201 |
| P/E Ratio | 38.11 | N/A | 21.54 |
| Revenue | 10.6B | 2.28B | 17.6B |
| Total Cash | 1.66B | 33.1M | N/A |
| Total Debt | 5.25B | 1.41B | N/A |
ALC | ENOV | PHG | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 77 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | 77 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 87 | 98 | 76 | |
PRICE GROWTH RATING 1..100 | 86 | 61 | 62 | |
P/E GROWTH RATING 1..100 | 50 | 98 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 32 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (3) in the Electronic Production Equipment industry is somewhat better than the same rating for ALC (39) in the Hospital Or Nursing Management industry, and is significantly better than the same rating for ENOV (77) in the Industrial Machinery industry. This means that PHG's stock grew somewhat faster than ALC’s and significantly faster than ENOV’s over the last 12 months.
PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry, and is in the same range as ENOV (100) in the Industrial Machinery industry. This means that PHG's stock grew similarly to ALC’s and similarly to ENOV’s over the last 12 months.
PHG's SMR Rating (76) in the Electronic Production Equipment industry is in the same range as ALC (87) in the Hospital Or Nursing Management industry, and is in the same range as ENOV (98) in the Industrial Machinery industry. This means that PHG's stock grew similarly to ALC’s and similarly to ENOV’s over the last 12 months.
ENOV's Price Growth Rating (61) in the Industrial Machinery industry is in the same range as PHG (62) in the Electronic Production Equipment industry, and is in the same range as ALC (86) in the Hospital Or Nursing Management industry. This means that ENOV's stock grew similarly to PHG’s and similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (50) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ENOV (98) in the Industrial Machinery industry, and is somewhat better than the same rating for PHG (99) in the Electronic Production Equipment industry. This means that ALC's stock grew somewhat faster than ENOV’s and somewhat faster than PHG’s over the last 12 months.
| ALC | ENOV | PHG | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 57% | 3 days ago 69% | 3 days ago 74% |
| Stochastic ODDS (%) | 3 days ago 63% | 3 days ago 81% | 3 days ago 52% |
| Momentum ODDS (%) | 3 days ago 51% | 3 days ago 56% | 3 days ago 57% |
| MACD ODDS (%) | 3 days ago 55% | 3 days ago 65% | 3 days ago 62% |
| TrendWeek ODDS (%) | 3 days ago 58% | 3 days ago 79% | 3 days ago 62% |
| TrendMonth ODDS (%) | 3 days ago 50% | 3 days ago 75% | 3 days ago 60% |
| Advances ODDS (%) | N/A | 11 days ago 61% | 12 days ago 62% |
| Declines ODDS (%) | 7 days ago 55% | 7 days ago 77% | 3 days ago 65% |
| BollingerBands ODDS (%) | 3 days ago 67% | 3 days ago 76% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 53% | 3 days ago 51% | 3 days ago 56% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MVGLX | 17.73 | -0.17 | -0.95% |
| MFS Low Volatility Global Equity R3 | |||
| JDEAX | 50.52 | -0.61 | -1.19% |
| JPMorgan US Research Enhanced Equity A | |||
| FSRPX | 17.30 | -0.21 | -1.20% |
| Fidelity Select Retailing | |||
| VICVX | 23.33 | -0.63 | -2.63% |
| USA Mutuals Vice Institutional | |||
| EEMAX | 20.40 | -1.08 | -5.03% |
| Columbia Emerging Markets A | |||
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | -7.01% | ||
| CNMD - ENOV | 59% Loosely correlated | -2.34% | ||
| FELE - ENOV | 56% Loosely correlated | -2.27% | ||
| DOV - ENOV | 55% Loosely correlated | -1.67% | ||
| PH - ENOV | 53% Loosely correlated | -2.01% | ||
| ITT - ENOV | 52% Loosely correlated | -4.08% | ||
More | ||||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | -1.06% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 52% Loosely correlated | -3.05% | ||
| ALC - PHG | 49% Loosely correlated | -0.56% | ||
| CNMD - PHG | 46% Loosely correlated | -2.34% | ||
| ENOV - PHG | 43% Loosely correlated | -7.01% | ||
More | ||||